Routine Ophthalmological Examination Rates in Adults with Sickle Cell Disease Are Low and Must Be Improved
Open Access
- 16 February 2023
- journal article
- research article
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 20 (4) , 3451
Abstract
The American Academy of Ophthalmology and the National Heart, Lung and Blood Institute recommend patients with sickle cell disease (SCD) undergo dilated funduscopic exams (DFE) every 1–2 years to screen for sickle retinopathy. There is a paucity of data on the adherence rate to these guidelines; a retrospective study was performed to evaluate our institution’s adherence. A chart review of 842 adults with SCD, seen 3/2017–3/2021 in the Montefiore healthcare system (All Patients), was done. Only about half of All Patients (n = 842) had >1 DFE during the study period (Total Examined Patients, n = 415). The Total Examined Patients were categorized as screening, those without retinopathy (Retinopathy−, n = 199), or follow-up, including individuals previously diagnosed with retinopathy (Retinopathy+, n = 216). Only 40.3% of screening patients (n = 87) had DFE at least biennially. As expected, there was a significant decrease in the average DFE rate of the Total Examined Patients after the COVID-19 pandemic started (13.6%) compared to pre-COVID (29.8%, p < 0.001). Similarly, there was a significant decrease in the screening rate of Retinopathy− patients from 18.6% on average pre-COVID to 6.7% during COVID (p < 0.001). This data shows the sickle retinopathy screening rate is low and innovative approaches may need to be employed to remedy this issue.Keywords
Funding Information
- Office of Medical Student Research at the Albert Einstein College of Medicine
This publication has 13 references indexed in Scilit:
- Prevalence and Onset of Pediatric Sickle Cell RetinopathyOphthalmology, 2019
- Ischemia-Reperfusion Injury in Sickle Cell DiseaseThe American Journal of Pathology, 2019
- Knowledge, beliefs and practices regarding sickle cell eye disease of patients at the sickle cell unit, JamaicaPan African Medical Journal, 2019
- Awareness of ocular manifestations, complications, and treatment of sickle cell disease in the eastern province of Saudi Arabia: A cross-sectional studyMiddle East African Journal of Ophthalmology, 2019
- Clinical and Ophthalmic Factors Associated With the Severity of Sickle Cell RetinopathyAmerican Journal of Ophthalmology, 2019
- Risk Factors for Visual Impairment in Patients with Sickle Cell Disease in LondonEuropean Journal of Ophthalmology, 2016
- Laser therapy for retinopathy in sickle cell diseaseCochrane Database of Systematic Reviews, 2015
- The Mechanism of Retinal Photocoagulation – How Does the Laser Work?European Ophthalmic Review, 2009
- Risk factors for proliferative sickle retinopathy.British Journal of Ophthalmology, 1990
- Patterns of visual loss in untreated sickle cell retinopathyEye, 1988